Clinical Trial Update: Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial is evaluating combined intravitreal bevacizumab with topical timolol-dorzolamide eye drops for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• timolol-dorzolamide eye drops

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN